VMP Periodic Review Checklist · Naga Mounika Nuguri

Document type	Checklist
Topic area	Process Validation
Level	Beginner
Updated	September 2026

This is a ready-to-use checklist for reviewing a Validation Master Plan, on its scheduled calendar cycle or when a trigger event pulls the review forward. Replace every <<FILL: ...>> placeholder. A filled specimen follows.

Document control header

Field	Entry
Parent VMP document number	`<<FILL>>`
Review type	`<<FILL: scheduled / triggered>>`
Trigger, if applicable	`<<FILL>>`
Reviewer(s)	`<<FILL>>`
Review date	`<<FILL>>`

Checklist

#	Item	Pass / Fail / N/A	Evidence / notes
1	Current system and process inventory (see the paired GxP System and Process Inventory Register) compared line by line against the VMP’s stated scope; no undocumented gap found	`<<FILL>>`	`<<FILL>>`
2	Development phase assumed by the VMP still matches the company’s actual current phase	`<<FILL>>`	`<<FILL>>`
3	No new modality, facility, or manufacturing site has entered the program that the current scope logic does not clearly cover	`<<FILL>>`	`<<FILL>>`
4	Roles assigned in the VMP still match the current organization; any reorganization since the last review has been reflected	`<<FILL>>`	`<<FILL>>`
5	Every referenced regulation, guidance, or recommendation (FDA process validation guidance, ICH Q8/Q9/Q10, EU Annex 15, PIC/S PI 006) cited by its current version, not a superseded one	`<<FILL>>`	`<<FILL>>`
6	Risk classification matrix reviewed; no system’s actual use has changed enough to warrant re-scoring	`<<FILL>>`	`<<FILL>>`
7	Periodic review intervals assigned to Tier 1 and Tier 2 systems are being met in practice, not just stated in policy	`<<FILL>>`	`<<FILL>>`
8	Approval and review history is current and unambiguous about which version is in effect	`<<FILL>>`	`<<FILL>>`

Disposition

Field	Entry
Overall outcome	`<<FILL: VMP confirmed current as-is / minor update required / full revision required>>`
Follow-up actions, if any, with owner and due date	`<<FILL>>`
Next scheduled review date	`<<FILL>>`

Approvals

Role	Name	Signature	Date
Reviewer (Validation)	`<<FILL>>`
Approver (Quality Assurance)	`<<FILL>>`

Filled specimen

Acme Therapeutics pulled its VMP review forward six months ahead of the scheduled 24-month cycle when the CAR-T program moved from Phase 2 into its pivotal trial, per the phase-change trigger the VMP itself defines.

#	Item	Result	Evidence / notes
1	Inventory vs. scope	Pass	Current inventory matches stated scope; two new Tier 2 environmental monitoring instruments added and already scored in the risk matrix
2	Phase match	Fail, triggering the review	VMP still stated “Phase 2” rigor; program has moved into its pivotal trial, requiring the pivotal-trial-tier comparability protocol rules
5	Reference currency	Fail	Reference list still cited “PIC/S recommendations on qualification and validation” generically; updated to PIC/S PI 006-4, in force 1 October 2026

Disposition: minor update required, not a full revision. Section 4 (phase-appropriate rigor) updated to reflect the pivotal-trial-phase row as current, and the reference list corrected. Follow-up owner: VMP owner, due within 10 business days. Next scheduled review reset to the normal 24-month cycle from the update date.

Common inspection findings this checklist prevents

A VMP whose stated phase no longer matches the company’s actual phase, discovered only when an inspector asks and the answer does not match the document.
A superseded reference sitting in the VMP’s reference list past its replacement’s effective date.
A periodic review that happened on paper, signature and date recorded, without any of the actual content being checked against current reality.

How to adapt this checklist

Set your own calendar cycle in the disposition section; the specimen uses 24 months, adjust to your program’s risk profile.
Add any trigger specific to your organization, a licensing event or a change in ownership structure, beyond the ones listed here.
Keep every completed checklist on file; a single current checklist without a review history is itself a finding.